Sorrento Therapeutics News

Sorrento Therapeutics | 425: Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions

Sep 13, 2022 18:15 ET

Sorrento Therapeutics | 425: Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions

Jun 14, 2022 14:51 ET

Sorrento Therapeutics | 425: Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions

May 23, 2022 09:06 ET

Sorrento Therapeutics | 425: Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions

Mar 18, 2022 09:03 ET

Sorrento Therapeutics | 424B7: Prospectus

Mar 3, 2022 17:08 ET

Sorrento Therapeutics | 424B5: Prospectus

Dec 3, 2021 16:33 ET

Sorrento Therapeutics | EFFECT: Others

Jul 16, 2021 00:15 ET

Sorrento Therapeutics | 424B3: Prospectus

Jul 15, 2021 17:01 ET

Sorrento Therapeutics | EFFECT: Others

Jun 2, 2021 00:15 ET

Sorrento Therapeutics | 424B3: Prospectus

Jun 1, 2021 16:59 ET

Sorrento Therapeutics | EFFECT: Others

Apr 20, 2021 00:15 ET

Sorrento Therapeutics | 424B3: Prospectus

Apr 19, 2021 19:20 ET

Sorrento Therapeutics | EFFECT: Others

Apr 6, 2021 00:15 ET

Sorrento Therapeutics | 424B3: Prospectus

Apr 5, 2021 18:41 ET

Sorrento Therapeutics | 424B5: Prospectus

Dec 4, 2020 17:15 ET

Sorrento Therapeutics | 424B3: Prospectus

Dec 4, 2020 17:05 ET

Sorrento Therapeutics | 424B3: Prospectus

Oct 21, 2020 16:16 ET

Sorrento Therapeutics | EFFECT: Others

Oct 21, 2020 00:15 ET

Sorrento Therapeutics | EFFECT: Others

Oct 9, 2020 00:15 ET

Sorrento Therapeutics | 424B3: Prospectus

Oct 8, 2020 17:22 ET